Immunovant (IMVT) Stock: Buy, Sell, or Hold?
IMVT - Immunovant, Inc. Common Stock
$37.36
-0.74 (-1.94%)
âŧ
5d:
-4.5%
30d:
-12.3%
90d:
+13.63%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When IMVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: IMVT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: IMVT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: IMVT is currently trading at $37.36, which is considered slightly low relative to its 30-day fair value range of $39.33 to $43.50.
Technical Outlook: Technically, IMVT is in a strong uptrend. The price is currently testing key support at $37.19. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IMVT scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $48.88 (+30.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMVT is in a strong uptrend. The price is currently testing key support at $37.19. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IMVT scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $48.88 (+30.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$39.33 -
$43.50
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding IMVT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (29/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.8% below Wall St target ($48.88)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$39.33 -
$43.50
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$37.19
Resistance Level
$43.38
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.46
Wall Street Target
$48.88
(+30.8%)
Share & Embed Analysis
Last updated: September 11, 2026 11:26 PM ET
Data refreshes hourly during market hours. Next update: 12:26 AM
Data refreshes hourly during market hours. Next update: 12:26 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Tiago Girao
SELL
25760 shares
2026-04-23
Jay S Stout
SELL
2754 shares
2026-04-23
Jay S Stout
SELL
10132 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 54 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 44 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 53 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 48 HOLD |
Advanced IMVT Option Strategies
Professional options setups generated by AI based on today's IMVT price and gamma walls.
